IL112183A - Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases - Google Patents

Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases

Info

Publication number
IL112183A
IL112183A IL11218394A IL11218394A IL112183A IL 112183 A IL112183 A IL 112183A IL 11218394 A IL11218394 A IL 11218394A IL 11218394 A IL11218394 A IL 11218394A IL 112183 A IL112183 A IL 112183A
Authority
IL
Israel
Prior art keywords
aryl
substituted
hydrogen
alkyl
radical
Prior art date
Application number
IL11218394A
Other languages
English (en)
Other versions
IL112183A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL112183A0 publication Critical patent/IL112183A0/xx
Publication of IL112183A publication Critical patent/IL112183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11218394A 1993-12-31 1994-12-29 Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases IL112183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (2)

Publication Number Publication Date
IL112183A0 IL112183A0 (en) 1995-03-15
IL112183A true IL112183A (en) 2001-01-11

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11218394A IL112183A (en) 1993-12-31 1994-12-29 Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases

Country Status (21)

Country Link
US (1) US5789383A (sv)
EP (1) EP0661058B1 (sv)
JP (1) JP3828593B2 (sv)
KR (1) KR100358822B1 (sv)
CN (1) CN1119171C (sv)
AT (1) ATE255417T1 (sv)
AU (1) AU696629B2 (sv)
BR (1) BR9405308A (sv)
CA (1) CA2138933C (sv)
DE (2) DE4345062A1 (sv)
DK (1) DK0661058T3 (sv)
ES (1) ES2211874T3 (sv)
FI (1) FI117320B (sv)
HU (1) HU226374B1 (sv)
IL (1) IL112183A (sv)
MY (1) MY112888A (sv)
NO (1) NO317660B1 (sv)
PT (1) PT661058E (sv)
RU (1) RU2228195C2 (sv)
UA (1) UA41326C2 (sv)
ZA (1) ZA9410381B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
PL3464336T3 (pl) 2016-06-01 2022-05-16 Athira Pharma, Inc. Związki

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
HUT65328A (en) * 1991-04-01 1994-05-02 Cortech Process for producing bradykinin antagonists
DE69226708T2 (de) * 1991-04-19 1999-04-15 Scios Nova Inc., Mountain View, Calif. Bradykinin typische peptide
DE69231918D1 (de) * 1991-04-19 2001-08-09 Scios Nova Inc Peptidantagonisten des bradykinin
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
RU2043115C1 (ru) * 1992-06-11 1995-09-10 Товарищество с ограниченной ответственностью "Резонанс-фарма" Средство, повышающее выживаемость и облегчающее течение вирусной инфекции - экстромелии в эксперименте
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists

Also Published As

Publication number Publication date
JP3828593B2 (ja) 2006-10-04
KR100358822B1 (ko) 2003-01-24
FI117320B (sv) 2006-09-15
ZA9410381B (en) 1995-08-29
BR9405308A (pt) 1995-09-19
KR950016779A (ko) 1995-07-20
DK0661058T3 (da) 2004-04-05
AU8179194A (en) 1995-07-13
JPH07206703A (ja) 1995-08-08
AU696629B2 (en) 1998-09-17
IL112183A0 (en) 1995-03-15
CN1108138A (zh) 1995-09-13
CN1119171C (zh) 2003-08-27
CA2138933A1 (en) 1995-07-01
RU94045140A (ru) 1996-10-20
FI950010L (sv) 1995-07-01
DE4345062A1 (de) 1995-07-13
NO317660B1 (no) 2004-11-29
NO945094L (no) 1995-07-03
MY112888A (en) 2001-10-31
ES2211874T3 (es) 2004-07-16
UA41326C2 (uk) 2001-09-17
HU9403783D0 (en) 1995-02-28
ATE255417T1 (de) 2003-12-15
RU2228195C2 (ru) 2004-05-10
CA2138933C (en) 2010-02-23
FI950010A0 (sv) 1995-01-02
NO945094D0 (no) 1994-12-30
DE59410340D1 (de) 2004-01-15
EP0661058A1 (de) 1995-07-05
HUT71422A (en) 1995-11-28
PT661058E (pt) 2004-04-30
EP0661058B1 (de) 2003-12-03
US5789383A (en) 1998-08-04
HU226374B1 (en) 2008-10-28

Similar Documents

Publication Publication Date Title
KR100352541B1 (ko) 노나-및데카펩타이드와,이를포함하는후천성면역결핍증치료용약제학적조성물
AU713424B2 (en) Heptapeptide oxytocin analogues
HU221092B1 (en) Compounds with growth hormone releasing properties
EP0239716B1 (en) Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
CA2138933C (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
US20060276390A1 (en) Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
KR20000076211A (ko) 택산과 조합된 돌라스태틴-15 유도체
AU677290B2 (en) Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis
EP0564972A2 (de) Peptide mit Modifikationen am N-Terminus mit bradykinenantagonistischer Wirkung
WO1999051254A1 (en) Short peptides for treatment of neurological degenerative diseases
US11021526B2 (en) DSG2-derived peptides
CA2393755C (en) Methods for treating and preventing damage to mucosal tissue
KR100273620B1 (ko) 레트로바이러스 감염의 억제방법
US6245736B1 (en) Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease
KR940010032B1 (ko) 고혈압 치료용 약제학적 조성물의 제조방법
EP0455133A2 (de) Peptide mit bradykinin-antagonistischer Wirkung
Wleklik et al. Tuftsin, a natural peptide with antiviral activity-structural basis of its action
HU224715B1 (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
EP0537291A1 (en) Method of treating nausea and emesis related to motion sickness
CA2004571A1 (en) Transdermal and intranasal administration of renin inhibitory peptides
US20050101539A1 (en) Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
EP0303243A2 (de) Verwendung von atrionatriuretischem Faktor (ANF), dessen Teilsequenzen und Analogen zur Behandlung von Herzerkrankungen
LT3375B (en) Peptides and pharmaceutical composition containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired